<p>A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof, wherein the variants R, R9, Z, X, Q and Y are defined in the specification.</p>
申请公布号
SI1720859(T1)
申请公布日期
2010.04.30
申请号
SI20050030940T
申请日期
2005.02.10
申请人
NOVARTIS AG
发明人
HERSPERGER RENE;JANSER PHILIPP;PFENNINGER EMIL;WUETHRICH HANS JUERG;MILTZ WOLFGANG
